Gamma-hydroxybutyrate poisoning from toy beads

Naren Gunja1, Evelyn Doyle, Kevin Carpenter

  • 1NSW Poisons Information Centre, The Children's Hospital at Westmead, Sydney, NSW, Australia. NarenG@chw.edu.au

Insights

Two children experienced decreased consciousness after ingesting toy beads. The beads contained 1,4-butanediol, which the body converts to gamma-hydroxybutyrate (GHB), leading to a product recall.

Area of Science:

  • Toxicology
  • Pediatric Emergency Medicine
  • Consumer Product Safety

Background:

  • Gamma-hydroxybutyrate (GHB) is a central nervous system depressant with potential for abuse.
  • Accidental ingestion of toxic substances in children is a significant public health concern.
  • The metabolism of precursor chemicals to GHB can lead to unexpected toxicity.

Observation:

  • Two pediatric patients presented with altered mental status, including decreased consciousness.
  • One patient experienced persistent vomiting and a seizure.
  • Urine metabolic screening revealed elevated levels of gamma-hydroxybutyrate (GHB).

Findings:

  • Toy beads ingested by the children were analyzed and found to contain 1,4-butanediol.
  • 1,4-butanediol is a known precursor that is metabolized to gamma-hydroxybutyrate (GHB) in the human body.
  • The clinical presentation was consistent with gamma-hydroxybutyrate (GHB) toxicity.

Implications:

  • This case highlights the potential danger of consumer products containing hidden toxic precursors.
  • Prompt identification of the toxic agent and its metabolic pathway was crucial for patient management.
  • The findings led to regulatory action, including an international recall of the contaminated toy beads, preventing further exposures.

Related Concept Videos

Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...